The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Golubova T.F.

Scientific Research Institute of Children’s Balneology, Physiotherapy and Medical Rehabilitation, Evpatoria, Russia

Tsukurova L.A.

Kraevaia klinicheskaia bol'nitsa #1 im. prof. S.V. Ochapovskogo, Krasnodar

Korsunskaya L.L.

Georgievsky Medical Academy, Simferopol, Russia, Crimean Federal University Vernadsky, Simferopol, Russia

Osipyan R.R.

Kuban State Medical University, Krasnodar, Russia

Vlasenko S.V.

Georgievsky Medical Academy, Simferopol, Russia, Crimean Federal University Vernadsky, Simferopol, Russia

Savchuk E.A.

Vernadsky Crimean Federal University, Georgievsky Medical Academy , Simferopol, Russia

S100B protein in the blood of children with autism spectrum disorders

Authors:

Golubova T.F., Tsukurova L.A., Korsunskaya L.L., Osipyan R.R., Vlasenko S.V., Savchuk E.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12): 76‑83

DOI: 10.17116/jnevro201911912176

Read: 50684 times

Download PDF (RU)
Contact the author
Table of contents

S100B PROTEIN IN THE BLOOD OF CHILDREN WITH AUTISM SPECTRUM DISORDERS
S100B PROTEIN IN THE BLOOD OF CHILDREN WITH AUTISM SPECTRUM DISORDERS

To cite this article:

Golubova TF, Tsukurova LA, Korsunskaya LL, Osipyan RR, Vlasenko SV, Savchuk EA. S100B protein in the blood of children with autism spectrum disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12):76‑83. (In Russ.)
https://doi.org/10.17116/jnevro201911912176

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Autoimmune diseases of central nervous system and respiratory viral infe­ctions in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):39-46
The role of gene­tic poly­morphisms in folate meta­bolism genes in the mani­festation of migraine in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):47-52
Pera­mpanel treatment in IQSEC2-associated epileptic ence­phalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):143-149
Neurometabolic therapy with Cere­brolysin in patients with sepsis-associated ence­phalopathy. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):46-54
The effect of sevo­flurane and propofol on serum nuclear and mito­chondrial DNA in pediatric patients with craniosynostosis. Russian Journal of Anesthesiology and Reanimatology. 2024;(6):55-62
Problems of providing dental care to children using the example of the city of Chapaevsk, Samara region. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4):35-42
Modern view on the etiology of gallstone disease in children. Russian Journal of Evidence-Based Gastroenterology. 2024;(4):59-68
Diagnostic capa­bilities of sound-breathing test in asse­ssment of pulmonary ventilation function in children and adults (retrospective review and prospect). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):40-47
Risk-oriented approach to predicting exte­rnal inflammatory reso­rption in children with permanent teeth inju­ries. Stomatology. 2024;(6-2):42-46
Treatment of children with blunt spleen injury throughout 25-year period in Seva­stopol and the Repu­blic of Crimea. Piro­gov Russian Journal of Surgery. 2025;(2):67-76
Abstract:

Objective. To evaluate the plasma content of S100B protein in children with autism spectrum disorders (ASD). Material and methods. Forty-five children with autism (item F84 of ICD-10), aged from 6 to 15 years, were examined. The control group (KG) consisted of 25 healthy children. The study included examination by specialists, an assessment of the severity of the disease using the Children’s Rating Scale of Autism scale (CARS), evaluation of S100B in blood serum. Results. The content of S100B in children with autism was significantly higher in comparison with KG. The level of S100B in children with ASD with abnormal development of brain structures (MRI) was significantly higher compared with KG and a group of children without signs of disturbance of brain structures. S100B levels were higher in children with severe ASD, and differed from controls in children with moderate ASD. Conclusions. The majority of children with ASD show signs of stress of neuroprotective mechanisms, and children with anomalies of brain structures have signs of hypoxia of the brain and damage of the blood-brain barrier.

Keywords:

autism
children
Children’s Rating Scale of Autism (CARS)
S100B protein
disturbance of the blood-brain barrier

Authors:

Golubova T.F.

Scientific Research Institute of Children’s Balneology, Physiotherapy and Medical Rehabilitation, Evpatoria, Russia

Tsukurova L.A.

Kraevaia klinicheskaia bol'nitsa #1 im. prof. S.V. Ochapovskogo, Krasnodar

Korsunskaya L.L.

Georgievsky Medical Academy, Simferopol, Russia, Crimean Federal University Vernadsky, Simferopol, Russia

Osipyan R.R.

Kuban State Medical University, Krasnodar, Russia

Vlasenko S.V.

Georgievsky Medical Academy, Simferopol, Russia, Crimean Federal University Vernadsky, Simferopol, Russia

Savchuk E.A.

Vernadsky Crimean Federal University, Georgievsky Medical Academy , Simferopol, Russia

Close metadata

References:

  1. Filippova NV, Barylnik YuB. Neuropathological and immunological aspects of the development of autism spectrum disorders. Bulletin of Online Medical Conferences. 2013;3(11):1198-1202. (In Russ.)
  2. Filippova NV, Barylnik YuB. Neurochemical aspects of the etiopathogenesis of autism spectrum disorders. Siberian Medical Bulletin. 2013;8:11-15. (In Russ.)
  3. Petit E, Hérault J, Martineau J, Perrot A, Barthélémy C, Hameury L, Sauvage D, Lelord G, Müh JP. Association study with two markers of a human homeogene in autism. J Med Genet. 1995;32(4):269‐274. https://doi.org/10.1136/jmg.32.4.269
  4. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev. 2003;25(6):377-382.
  5. Wegiel J, Flory M, Kuchna I, Nowicki K, Ma SY, Imaki H, Wegiel J, Cohen IL, London E, Wisniewski T, Brown WT. Stereological study of the neuronal number and volume of 38 brain subdivisions of subjects diagnosed with autism reveals significant alterations restricted to the striatum, amygdala and cerebellum. Acta Neuropathol Commun. 2014;2:141. https://doi.org/10.1186/s40478-014-0141-7
  6. Kern JK. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev. 2003;25(6):377-382.
  7. Vetchinkina YuV, Skoromets AP. Search for biomarkers of cerebral hypoxia in newborns. Bulletin of the Komi Science Center, Ural Branch of the Russian Academy of Sciences. 2013;1(13):56-62. (In Russ.)
  8. Zarubin AA, Mikheeva NI, Filippov ES, Belogorova TA, Vanyarkina AS, Shishkina AA. Hypoxic-ischemic encephalopathy of newborns born in severe asphyxiation. Bulletin of the VSSC SB RAMS. 2017;2(114):95-101. (In Russ.)
  9. Skoromets AA, Dambinova SA, Dyakonov MM, Granstrem OK, Biletsky PS, Sedova OA, Skoromets AP, Smolko DG, Khunteev GV, Shikuev AV, Shumilina MV. Biochemical markers in the diagnosis of cerebral ischemia. International Neurological Journal. 2009;5(27):15-20. (In Russ.)
  10. Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis. 2009;27(1):37-41. https://doi.org/10.1159/000172632.
  11. Foerch C, Otto B, Singer OC, Neumann-Haefelin T, Yan B, Berkefeld J, Steinmetz H, Sitzer M. Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion. Stroke. 2004;35(9):2160-2164. https://doi.org/10.1161/01.STR.0000138730.03264.ac
  12. Khakimova GR, Voronina TA, Dugina YuL, Ertuzun IA, Epshtein OI. The spectrum of pharmacological effects of antibodies to protein S 100 in a real-active form and mechanisms for their implementation. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2016;4:100-113. (In Russ.) https://doi.org/10.17116/jnevro201611641100-113
  13. Michetti F, Corvino V, Geloso MC, Lattanzi W, Bernardini C, Serpero L, Gazzolo D. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. Journal of Neurochemistry. 2012;120(5):644-659. https://doi.org/10.1111/j.1471-4159.2011.07612.x
  14. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C, Giambanco I. S100B’s double life: Intracellular regulator and extracellular signal. Biochimica et Biophysica Acta (BBA) — Molecular Cell Research. 2009;1793(6):1008-1022. https://doi.org/10.1016/j.bbamcr.2008.11.009
  15. Scotto G, Deloulme JC, Rousseau D, Chambaz E, Baudier J. Calcium and S100B Regulation of p53-Dependent Cell Growth Arrest and Apoptosis. Mol Cell Biol. 1998;18(7):4272-4281. https://doi.org/10.1128/MCB.18.7.4272
  16. Pavlushkina L, Chernevskaya E, Dmitrieva I, Beloborodova N. Bio-markers in clinical practice. Clinic. 2013;3:10-14. (In Russ.)
  17. Adami C, Sorci G, Blasi E, Agneletti AL, Bistoni F, Donato R. S100B expression in and effects on microglia. Glia. 2001;33(2):131-142.
  18. Rothermundt M, Peters M, Prehn JH, Arolt V. S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003;60(6):614-632. https://doi.org/10.1002/jemt.10303
  19. Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, Sakas DE. Serum S-100B Protein as A Biochemical Marker of Brain Injury: Review of Current Concepts. CMC. 2006;13(30):3719-3731. https://doi.org/10.2174/092986706779026129
  20. Rothermundt M, Arolt V, Wiesmann M, Missler U, Peters M, Rudolf S, Kirchner H. S-100B is increased in melancholic but not in non-melancholic major depression. Journal of Affective Disorders. 2001;66(1):89-93. https://doi.org/10.1016/s0165-0327(00)00321-9
  21. Golosnaya GS, Petrukhin AS, Markevich KA, Trifonova OE. Change in the level of S-100 protein in newborns with perinatal hypoxic damage to the central nervous system. Pediatrics. 2004;1:1-6. (In Russ.)
  22. Krasnorutskaya ON, Balakireva EA, Zuykova AA, Dobrynina IS. Assessment of the degree of participation of biochemical markers of perinatal damage to the central nervous system in children. Bulletin of New Medical Technologies. 2014;21(2):26-29. (In Russ.) https://doi.org/10.12737/4991
  23. Krasnorutskaya ON, Balakireva EA, Bugrimov DYu, Tsvetikova LN, Petrova TN. The severity of neurological deficits in young children based on the assessment of neurobiochemical markers. Bulletin of New Medical Technologies. 2014;1:1-6. (In Russ.) https://doi.org/10.12737/4109
  24. Samsonova TV, Benis NA, Nazarov SB, Kuzmenko GN. Diagnostic value of indicators of protein S100 and neurotrophic factor of the brain BDNF in the blood in very premature infants. Mother and Child in Kuzbass. 2015;4(63):40-42. (In Russ.)
  25. Serikova IYu, Vorobyova EN, Shumacher GI. Immunobiochemical markers of nervous system damage in adolescents with long-term consequences of perinatal CNS pathology. Journal of Siberian Medical Sciences. 2014;2:1-7. (In Russ.)
  26. Lloyd E, Lederman W, Tyurin YuN. Handbook of Applied Statistics. M.: Finance and statistics. 1989—1990;1:266:2:211. (In Russ.)
  27. Martsenkovsky IA. Autism spectrum disorders: diagnostic features, prevention and treatment options. Archive of Psychiatry. 2012;2(69):84-90. (In Russ.)
  28. Poletaev AB. Antibodies to antigens of nervous tissue and pathology of the nervous system. Vestnik «MEDSI». 2011;3:14-21. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.